ArticleJournal of cardiothoracic surgery2025
Vasculoprotective role of del Nido cardioplegia in open-heart surgery via modulation of E-Selectin, Endocan, and TNF-alpha coronary sinus blood samples.
Article in Journal of cardiothoracic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Modified Del Nido Cardioplegia with a 1:4 Crystalloid-to-Blood Ratio Versus Blood-Based St. Thomas Cardioplegia in Isolated Aortic Valve Replacement.Journal of cardiovascular development and disease · 2026Article
- Cardioplegia modalities and systemic redox status in younger vs. older patients undergoing cardiac surgery.Molecular biology reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeCardioplegia is routinely used in cardiac surgery to prevent endothelial damage associated with ischemia-reperfusion. However, there is no consensus on the optimal vasculoprotective cardioplegia. We aim to assess endothelial integrity using coronary sinus blood samples in patients who have received various types of cardioplegia.
methodsAortic valve replacement for aortic stenosis and isolated coronary artery bypass grafting patients were included. del Nido and blood cardioplegias were subjected to assessment. Blood samples from the coronary sinus were collected before and after aortic cross-clamping. Endothelial and redox biomarkers were assessed utilizing immunochemical and colorimetric techniques.
resultsIn coronary artery bypass grafting patients, E-selectin levels were found significantly lower after cross-clamping compared to pre-clamp values, regardless of cardioplegia type (p = 0.015). ROC analysis revealed that Endocan, E-selectin, and TNF-α levels are reliable biomarkers of endothelial injury after cardiopulmonary bypass (p values: 0.004, 0.007, and < 0.001 for each parameter, respectively). Total oxidant status emerged as a significant redox biomarker, with 87% ROC sensitivity (p = 0.037).
conclusionThis study uniquely assesses localized endothelial responses via coronary sinus sampling with a multiplex biomarker panel, providing evidence of del Nido cardioplegia's protection. Our findings indicate that del Nido cardioplegia exhibits significant vasculoprotection, as evidenced by modulation of coronary sinus Endocan, E-selectin, and TNF-α. These biomarker changes, together with the absence of adverse differences in major postoperative outcomes, suggest that del Nido cardioplegia provides efficient myocardial and vascular protection in both aortic valve replacement and coronary artery bypass procedures, supporting its safe use in adult elective cardiac surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.